Interactive Decision Support Tool: Current Considerations for Managing Patients Taking an Opioid for Chronic Pain

Content Format:

Tool

Credit Type:

--

Credits:

--
Answering Your Questions: Managing Patients on Opioid Analgesics

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Managing Patients on Opioid Analgesics

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC | APA | ASWB ACE

Credits:

1.00
Managing Patients on Opioid Analgesics

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: When to Consider an Opioid

Content Format:

Tool

Credit Type:

--

Credits:

--
Guidance on Opioid Tapering

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Insight on Therapy Selection for Unresectable Stage III and Metastatic NSCLC

Content Format:

Tool

Credit Type:

--

Credits:

--
Treatment Options From 5 Experts for People With Unresectable Stage III or Metastatic NSCLC: An Online Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Using Immunotherapy to Treat Advanced Squamous NSCLC: Where Are We Now?

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Immunotherapy for Advanced NSCLC: Discussing Goals and Treatments With Your Health Care Providers

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Shared Decision-Making and the Current Landscape of Checkpoint Inhibitor Therapy in Metastatic NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
The Why and Who: Overview of Immune Checkpoint Blockade in Lung Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How

Content Format:

Multimedia

Credit Type:

ABPath MOC | AMA

Credits:

1.00
Optimal Treatment of Unresectable, Stage III NSCLC

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Treating a Patient With Newly Diagnosed Metastatic Squamous NSCLC and Low PD-L1 Expression

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Treating a Patient With Newly Diagnosed Metastatic Lung Adenocarcinoma and &lt 1% PD-L1 Expression

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Immunotherapy and Targeted Therapy in NSCLC: Where Are We Going in 2018?

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--